Overview

MindMaze is a Swiss-founded brain-technology company developing neurorehabilitation platforms that combine neuroscience, biosensing, engineering, mixed reality, and artificial intelligence. The company was founded in Lausanne in 2012 by Tej Tadi, an EPFL PhD graduate, and is one of the longer-running commercial-stage neurotechnology companies in Europe. MindMaze reached unicorn status in 2016 with a reported $1.5 billion valuation, making it the first European neurotechnology unicorn.

Mission and products

MindMaze’s mission is to accelerate humanity’s ability to recover, learn, and adapt by combining clinical-grade neuroscience with mixed-reality interfaces and AI-driven personalisation. The company’s core commercial focus has been on stroke recovery and neurorehabilitation, with platforms used in clinical and home settings to support patients regaining motor and cognitive function after neurological injury.

Strategic position in the Lausanne-Geneva cluster

MindMaze is one of three significant neurotechnology companies that trace their origins to the EPFL Lausanne / Campus Biotech Geneva academic cluster, alongside ONWARD Medical (Courtine / Bloch brain-spine interface spinout) and Neurosoft Bioelectronics (Lacour soft-electrode spinout). The combined commercial output positions Lausanne-Geneva as one of Europe’s most coordinated multi-faculty multi-company neurotechnology engines, with MindMaze representing the longer-running incumbent in the cluster’s commercial track record.